These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27049496)
1. Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression. Zepeda-Morales AS; Del Toro-Arreola S; García-Benavides L; Bastidas-Ramírez BE; Fafutis-Morris M; Pereira-Suárez AL; Bueno-Topete MR Ann Hepatol; 2016; 15(3):418-26. PubMed ID: 27049496 [TBL] [Abstract][Full Text] [Related]
2. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc. Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650 [TBL] [Abstract][Full Text] [Related]
4. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats. Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286 [TBL] [Abstract][Full Text] [Related]
6. TGF-β1 and TGF-β2 abundance in liver diseases of mice and men. Dropmann A; Dediulia T; Breitkopf-Heinlein K; Korhonen H; Janicot M; Weber SN; Thomas M; Piiper A; Bertran E; Fabregat I; Abshagen K; Hess J; Angel P; Coulouarn C; Dooley S; Meindl-Beinker NM Oncotarget; 2016 Apr; 7(15):19499-518. PubMed ID: 26799667 [TBL] [Abstract][Full Text] [Related]
8. The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct-ligated rats. Díaz-Gil JJ; García-Monzón C; Rúa C; Martín-Sanz P; Cereceda RM; Miquilena-Colina ME; Machín C; Fernández-Martínez A; García-Cañero R Histol Histopathol; 2008 May; 23(5):583-91. PubMed ID: 18283643 [TBL] [Abstract][Full Text] [Related]
9. Effect of tamoxifen on fibrosis, collagen content and transforming growth factor-β1, -β2 and -β3 expression in common bile duct anastomosis of pigs. Siqueira OHK; Oliveira KJ; Carvalho ACG; da Nóbrega ACL; Medeiros RF; Felix-Patrício B; Áscoli FO; Olej B Int J Exp Pathol; 2017 Oct; 98(5):269-277. PubMed ID: 29205609 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats. Sheen-Chen SM; Lin CR; Chen KH; Yang CH; Lee CT; Huang HW; Huang CY J Gastroenterol; 2014 Aug; 49(8):1285-97. PubMed ID: 24097032 [TBL] [Abstract][Full Text] [Related]
11. Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. Gordillo-Bastidas D; Oceguera-Contreras E; Salazar-Montes A; González-Cuevas J; Hernández-Ortega LD; Armendáriz-Borunda J World J Gastroenterol; 2013 Dec; 19(47):9020-33. PubMed ID: 24379627 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms. Biecker E; De Gottardi A; Neef M; Unternährer M; Schneider V; Ledermann M; Sägesser H; Shaw S; Reichen J J Pharmacol Exp Ther; 2005 Jun; 313(3):952-61. PubMed ID: 15769867 [TBL] [Abstract][Full Text] [Related]
13. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168 [TBL] [Abstract][Full Text] [Related]
14. Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation. Zhang X; Xu Y; Chen JM; Liu C; Du GL; Zhang H; Chen GF; Jiang SL; Liu CH; Mu YP; Liu P Am J Chin Med; 2017; 45(1):85-104. PubMed ID: 28081630 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751 [TBL] [Abstract][Full Text] [Related]
16. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. Neef M; Ledermann M; Saegesser H; Schneider V; Reichen J J Hepatol; 2006 Dec; 45(6):786-96. PubMed ID: 17050028 [TBL] [Abstract][Full Text] [Related]
17. The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis. Liang J; Zhang B; Shen RW; Liu JB; Gao MH; Geng X; Li Y; Li YY; Zhang W Scand J Immunol; 2014 Mar; 79(3):163-72. PubMed ID: 24383550 [TBL] [Abstract][Full Text] [Related]
18. Trolox mitigates fibrosis in a bile duct ligation model. Galicia-Moreno M; Favari L; Muriel P Fundam Clin Pharmacol; 2013 Jun; 27(3):308-18. PubMed ID: 22211361 [TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats]. Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076 [TBL] [Abstract][Full Text] [Related]
20. Changes in serum cytokine concentration: a morphological study of liver cirrhosis induced by common bile duct ligation in rats. Lee BS; Kim NJ; Jeong HY; Lee HY; Kang DY; Noh SM Korean J Intern Med; 2003 Mar; 18(1):6-12. PubMed ID: 12760262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]